BLFS

Biolife Solutions Stock Analysis

AI Rating

Fair
  • Quality3/10
  • Growth↑ 8/10
  • Value↓ 0/10
Biolife Solutions sales and earnings growth
BLFS Growth
Good
  • Revenue Y/Y↑ 28.89%
  • EPS Y/Y↑ 79.55%
  • FCF Y/Y↓ -114.99%
Biolife Solutions gross and profit margin trends
BLFS Profitability
Neutral
  • Gross margin ↑ 64.60%
  • EPS margin↓ -4.80%
  • ROIC 5Y↓ -35.27%
Biolife Solutions net debt vs free cash flow
BLFS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -2.7

Biolife Solutions stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗